o
(866) 258-2735

Solutions

The iMednet eClinical platform offers a cost-effective solution with a full suite of native tools to simplify and shorten study build times, increase efficiency in study execution, and minimize costs through the duration of the study.

View All
Review of FDA Guidance for Adaptive Trial Designs

Review of FDA Guidance for Adaptive Trial Designs

This is the third installment of a three-part blog series on Complex Innovative Trial Designs.  As we’ve discussed previously, clinical trials are evolving rapidly, with new data sources and medical innovation increasing the complexity of study designs. The FDA...
FDA’s Guidance on Complex Innovative Trial Designs

FDA’s Guidance on Complex Innovative Trial Designs

As discussed in our last blog, with advances in medical science and new data sources, study design complexity is on the rise. The US FDA continues to show interest and support for these new and innovative science and clinical trial designs, initiating programs and...
Complex Innovative Trial Design to Support Innovation

Complex Innovative Trial Design to Support Innovation

As medical science continues to advance and new technologies and data sources emerge, the US FDA continues to show interest and support for innovative science and clinical trial designs. The agency has committed to increasing the capacity of their internal teams...
We’re Here to Help You Achieve Success

We’re Here to Help You Achieve Success

As clinical trials become increasingly complex with a growing pressure to build and execute studies as quickly as possible, getting a study set up and running quickly is paramount to success. We continually work to enhance iMednet’s user experience and we frequently...
How Our Product Strategy Addresses Clinical Trial Trends

How Our Product Strategy Addresses Clinical Trial Trends

As discussed in our last blog, we see three BIG trends impacting clinical trials and how they are conducted. As the clinical trials industry rapidly evolves, we anticipate these trends to not only continue, but potentially grow, in the foreseeable future. They are:...